P/E ratio for Molina Healthcare (MOH)
P/E ratio as of April 2024 (TTM): 21.8
According to Molina Healthcare 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 21.8068. At the end of 2022 the company had a P/E ratio of 24.1.
P/E ratio history for Molina Healthcare from 2003 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 24.1 | -13.53% |
| 2021 | 27.9 | 49.13% |
| 2020 | 18.7 | 63.3% |
| 2019 | 11.4 | 13.62% |
| 2018 | 10.1 | -215.38% |
| 2017 | -8.73 | -103.11% |
| 2016 | 280 | 1175.73% |
| 2015 | 22.0 | -47.05% |
| 2014 | 41.5 | 38.57% |
| 2013 | 30.0 | -76.75% |
| 2012 | 129 | 153.91% |
| 2011 | 50.8 | 261.72% |
| 2010 | 14.0 | -27% |
| 2009 | 19.2 | 139% |
| 2008 | 8.04 | -57.2% |
| 2007 | 18.8 | -5.23% |
| 2006 | 19.8 | -25.59% |
| 2005 | 26.6 | 19.47% |
| 2004 | 22.3 | 68.8% |
| 2003 | 13.2 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Cigna CI | 19.9 | -8.96% | 🇺🇸 USA |
 Humana HUM | 12.9 | -41.06% | 🇺🇸 USA |
 Anthem ANTM | 18.8 | -13.93% | 🇺🇸 USA |
 Magellan Health
MGLN | N/A | N/A | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.